Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 13 of about 6 companies and 7 funds for James Garner
Company Exchange Symbol Last price Quote change Market cap
Novogen Limited (ADR) NASDAQ NVGN 1.84 -0.01 (-0.54%) 31.25M
Novogen Limited (Novogen) is a drug discovery company. The Company is primarily engaged in pharmaceutical research and development.
Executive:
James B. Garner
Zogenix, Inc. NASDAQ ZGNX 8.62 -0.04 (-0.46%) 212.54M
Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical ...
Executive:
James B. Breitmeyer MD, Ph.D.
Alphatec Holdings Inc NASDAQ ATEC 0.390 +0.030 (8.33%) 43.30M
Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine) ...
Executive:
James M. Corbett
Coastal Banking Company, Inc. OTCMKTS CBCO 13.00 +0.04 (0.31%) 34.88M
Coastal Banking Company, Inc. is a bank holding company for CBC National Bank ( the Bank). The Bank provides a range of commercial and consumer banking ...
Executive:
James C. Key
Agile Therapeutics Inc NASDAQ AGRX 6.86 +0.20 (3.00%) 203.10M
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of ...
Executive:
James Patrick Tursi MD
Novogen Limited ASX NRT 0.0980 +0.0010 (1.03%) 42.11M
Novogen Limited (Novogen) is a drug discovery company. The Company is primarily engaged in pharmaceutical research and development.
Executive:
James B. Garner
Mutual Fund Symbol Nav Nav change
Principal SmallCap Growth Fund II Class J PPMIX 8.86 -0.28 (-3.06%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II Class Institutional PSIIX 10.82 -0.34 (-3.05%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II R-5 Class PPMPX 10.34 -0.33 (-3.09%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II R-2 Class PPMNX 9.34 -0.29 (-3.01%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II R-1 Class PPASX 9.71 -0.31 (-3.09%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II R-4 Class PPMSX 10.08 -0.32 (-3.08%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey
Principal SmallCap Growth Fund II R-3 Class PPMMX 9.79 -0.31 (-3.07%)
The investment seeks long-term growth of capital. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for ...
Executive:
James W. Fennessey